Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
Daiichi Sankyo
Cipla
Baxter
AstraZeneca
Cerilliant
Deloitte
Moodys
Johnson and Johnson

Generated: February 19, 2018

DrugPatentWatch Database Preview

IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Ionosol Mb And Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Ionosol Mb And Dextrose 5% In Plastic Container is a drug marketed by Icu Medical Inc and is included in one NDA.

The generic ingredient in IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium lactate; sodium phosphate, monobasic anhydrous. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium lactate; sodium phosphate, monobasic anhydrous profile page.

US Patents and Regulatory Information for IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium lactate; sodium phosphate, monobasic anhydrous INJECTABLE;INJECTION 019513-001 May 8, 1986 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
UBS
AstraZeneca
Chinese Patent Office
Chubb
Citi
Queensland Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot